PROFUSA, INC. Earnings Per Share (Basic)
PROFUSA, INC. (PFSA) reported Earnings Per Share (Basic) of -$151.80 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-19
- PROFUSA, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$151.80.
- PROFUSA, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$2.05.
- PROFUSA, INC. earnings per share, basic for the quarter ending 2025-12-31 was $0.25, a 36.80% decline year-over-year.
- PROFUSA, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.70.
- PROFUSA, INC. earnings per share, basic for fiscal 2023 was $0.12, a 60.00% decline from fiscal 2022.
- PROFUSA, INC. earnings per share, basic for fiscal 2022 was $0.30.
| Period end | Earnings Per Share, Basic 2 month | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 5 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 8 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$151.80 10-Q · filed 2026-08-19 | -$326.74 10-Q · filed 2026-08-19 | $1.91 derived: net income ÷ weighted average shares · filed 2026-08-19 | $190.66 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||||||
| 2026-03-31 | -$2.05 10-Q · filed 2026-05-15 | $0.74 derived: net income ÷ weighted average shares · filed 2026-08-19 | $107.02 derived: net income ÷ weighted average shares · filed 2026-08-19 | $152.52 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||||||
| 2025-12-31 | $0.25 derived: net income ÷ weighted average shares · filed 2026-05-01 | $23.24 derived: net income ÷ weighted average shares · filed 2026-05-01 | $37.52 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$107.01 S-1/A · filed 2026-05-01 | |||||||
| 2025-09-30 | -$0.70 10-Q · filed 2025-11-19 | -$1.55 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$2.29 10-Q · filed 2025-11-19 | -$4.53 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||||||
| 2025-06-30 | -$9100.78 10-Q · filed 2026-08-19 | -$1.53 10-Q · filed 2025-08-14 | -$19627.91 10-Q · filed 2026-08-19 | -$1.66 10-Q · filed 2025-08-14 | $3.86 derived: net income ÷ weighted average shares · filed 2026-08-19 | $10.47 derived: net income ÷ weighted average shares · filed 2026-08-19 | |||||
| 2025-03-31 | -$105.09 10-Q · filed 2026-05-15 | -$0.19 10-Q · filed 2025-06-13 | $1.75 derived: net income ÷ weighted average shares · filed 2026-08-19 | $5.98 derived: net income ÷ weighted average shares · filed 2026-08-19 | -$27.31 derived: net income ÷ weighted average shares · filed 2026-08-19 | ||||||
| 2024-12-31 | $0.39 derived: net income ÷ weighted average shares · filed 2026-05-01 | $2.52 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$15.12 derived: net income ÷ weighted average shares · filed 2026-05-01 | -$357.14 S-1/A · filed 2026-05-01 | -$1.47 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | -$1.29 10-Q · filed 2025-11-19 | $0.02 10-Q · filed 2024-12-17 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$3.60 10-Q · filed 2025-11-19 | -$0.19 10-Q · filed 2024-12-17 | -$1.54 derived: net income ÷ weighted average shares · filed 2025-11-19 | |||||
| 2024-06-30 | -$0.07 10-Q · filed 2025-08-14 | -$0.20 10-Q · filed 2025-08-14 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-11-19 | |||||||
| 2024-03-31 | -$0.14 10-Q · filed 2025-06-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.42 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-11-19 | |||||||
| 2023-12-31 | $0.05 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2025-03-31 | $0.14 derived: net income ÷ weighted average shares · filed 2025-03-31 | $0.12 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | -$0.06 10-Q · filed 2024-12-17 | $0.09 derived: net income ÷ weighted average shares · filed 2024-12-17 | $0.08 10-Q · filed 2024-12-17 | $0.27 derived: net income ÷ weighted average shares · filed 2024-12-17 | |||||||
| 2023-06-30 | $0.14 10-Q · filed 2024-11-15 | $0.09 10-Q · filed 2024-11-15 | $0.34 derived: net income ÷ weighted average shares · filed 2024-12-17 | $0.68 derived: net income ÷ weighted average shares · filed 2024-12-17 | |||||||
| 2023-03-31 | $0.02 10-Q · filed 2024-10-09 | $0.18 derived: net income ÷ weighted average shares · filed 2024-12-17 | $0.52 derived: net income ÷ weighted average shares · filed 2024-12-17 | $0.75 derived: net income ÷ weighted average shares · filed 2024-12-17 | |||||||
| 2022-12-31 | $0.09 derived: net income ÷ weighted average shares · filed 2024-02-26 | $0.43 derived: net income ÷ weighted average shares · filed 2024-02-26 | $0.67 derived: net income ÷ weighted average shares · filed 2024-02-26 | $0.30 10-K · filed 2024-02-26 | |||||||
| 2022-09-30 | $0.07 10-Q · filed 2023-11-20 | $0.57 derived: net income ÷ weighted average shares · filed 2023-11-20 | $0.28 10-Q · filed 2023-11-20 | ||||||||
| 2022-06-30 | $0.05 10-Q · filed 2023-08-14 | $0.20 10-Q · filed 2023-08-14 | |||||||||
| 2022-03-31 | $0.15 10-Q · filed 2023-05-17 | ||||||||||
| 2021-12-31 | $0.06 10-K · filed 2023-03-06 | ||||||||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | ||||||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |